Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment
terumo.com

See what CB Insights has to offer

Investments

7

Portfolio Exits

2

Partners & Customers

10

Service Providers

1

About Terumo

Terumo (TYO:4543) manufactures and sells medical products and equipment, including pharmaceuticals, nutritional food supplement, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital termometers.

Terumo Headquarter Location

2-44-1 Hatagaaya Shibuya-ku

Tokyo, 151-0072,

Japan

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Terumo Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Terumo Rank

Latest Terumo News

Infusion Pumps Market Perspective, Comprehensive Analysis, Growth and Forecast 2020-2030

Nov 17, 2021

Infusion Pumps Market Perspective, Comprehensive Analysis, Growth and Forecast 2020-2030 FMI’s recent report on infusion pumps market projects to surge at a CAGR of 5.4% from 2020-2030. Growth is attributed to increasing diabetic population across prominent regions. As per World Health Organization’s projections, there were 422 million diabetic people as of 2014, with a 5% increase in premature mortality. Consequently, there has also been an increase in associated co-morbidities such as strokes, heart attacks, kidney failure and visual impairment. As a result, infusion pump usage has upticked in order to provide the appropriate medication and nutritional input. To facilitate efficient drug delivery, manufacturers have incorporated various technological advancements in recent years. Additionally, the advent of wearable and smart infusion pumps is further fueling the market’s revenue prospects. To Get Sample Copy of Report visit @  https://www.futuremarketinsights.com/reports/sample/REP-GB-859 Global Infusion Pumps Market- Key Takeaways Rising prevalence of cancer to push forward oncology-grade infusion pumps usage in the coming years Ambulatory pumps are poised to hold major sway in the wake of swift drug and nutrient delivery Europe to pivot global infusion pumps market growth, capturing over 1/3rd of the revenue pie Global infusion pumps market is likely to surpass US$ 6 Bn by 2030-end Favorable business reimbursement policies are expected to bolster infusion pumps demand in coming years COVID-19 Impact Analysis The COVID-19 pandemic is anticipated to have a moderate impact on the global infusion pumps market. In the initial months of the pandemic’s onset, a slump in the demand-supply equation was observed. This was in response to the imposition of lockdowns and social distancing protocols. Eventually, a resurgence was recorded. In recent months, regulatory authorities such as the U.S Food and Drug Administration (FDA) issued emergency use authorization to increase the availability of infusion pumps and related accessories. Infusion pumps have been pivotal in administering vital medicines and parenteral nutrition to patients admitted for chronic ailments. As hospitals reach a saturation point, governments are providing flexibility to infusion pump manufacturers to address supply shortages by permitting them to resume operations. This is slated to sustain the infusion pumps market demand in the short-term forecast. Global Infusion Pumps Market- Competitive Intelligence Prominent players in the infusion pumps landscape include Fresenius Kabi AG, Terumo Corporation, Medtronic Plc, Baxter International Plc., Smith Medical, MOOG Inc., Johnson & Johnson Services Inc., ICU Medical Inc. and Becton Dickinson & Company among others. Download PDF Brochure @  https://www.futuremarketinsights.com/reports/brochure/rep-gb-859   Detailed insights of market segments and sub-segments for historical as well as forecast period   A competitive analysis of prominent players and emerging players in the keyword market   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact Us:

Terumo Investments

7 Investments

Terumo has made 7 investments. Their latest investment was in CUORiPS as part of their Series B on December 12, 2020.

CBI Logo

Terumo Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/4/2020

Series B

CUORiPS

$19.2M

No

4

5/7/2019

Series B

Subscribe to see more

$99M

Subscribe to see more

10

7/11/2018

Series A

Subscribe to see more

$99M

Subscribe to see more

10

5/3/2017

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

10/7/2015

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/4/2020

5/7/2019

7/11/2018

5/3/2017

10/7/2015

Round

Series B

Series B

Series A

Corporate Minority

Corporate Minority

Company

CUORiPS

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$19.2M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

10

10

10

10

Terumo Portfolio Exits

2 Portfolio Exits

Terumo has 2 portfolio exits. Their latest portfolio exit was Vascutek on April 23, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/23/2018

Merger

2

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

4/23/2018

00/00/0000

Exit

Merger

Subscribe to see more

Companies

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Sources

2

10

Terumo Acquisitions

14 Acquisitions

Terumo acquired 14 companies. Their latest acquisition was Health Outcomes Sciences on February 23, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/23/2021

Convertible Note

$10.89M

Acquired

1

7/15/2020

Corporate Minority

$991

Acquired

6

11/20/2019

Option/Warrant

$7M

Acquired

1

7/25/2018

Subscribe to see more

$991

$99M

Subscribe to see more

10

2/14/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/23/2021

7/15/2020

11/20/2019

7/25/2018

2/14/2017

Investment Stage

Convertible Note

Corporate Minority

Option/Warrant

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Total Funding

$10.89M

$7M

$99M

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

6

1

10

10

Terumo Partners & Customers

10 Partners and customers

Terumo has 10 strategic partners and customers. Terumo recently partnered with Glooko on March 3, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

3/18/2021

Licensee

Glooko

United States

Terumo and Glooko Announce Diabetes Technology Partnership to Deliver Integrated Diabetes Data Solution Globally.

The partnership will enable the integration of data from Terumo Corporation 's diabetes care devices such as MEDISAFE insulin patch pump and MEDISAFE Fit SmileTM blood glucose meters into Glooko 's diasend ® diabetes data management platform .

1

1/5/2021

Licensor

IceCure Medical

Israel

IceCure Inks Expanded Distribution Agreement with Terumo Corporation for Thailand – IceCure Expanded Agreement Builds from the Success of its Current Joint Activities in Japan and Singapore, to Bring its Cryoablation Products to Benefit More Patients in Asia .

CAESAREA , Israel , January 5 , 2021 -- IceCure Medical Ltd. , developer of the next generation cryoablation technology that destroys tumors by freezing without the need for surgery , today announced that an expanded distribution agreement in Thailand with its strategic partner , Terumo Corporation , a leading Japanese medical devices company with a global footprint , was signed on December 28 , 2020 .

1

11/16/2020

Partner

Diabeloop

France

1

6/2/2020

Supplier

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

9/1/2019

Licensor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

3/18/2021

1/5/2021

11/16/2020

6/2/2020

9/1/2019

Type

Licensee

Licensor

Partner

Supplier

Licensor

Business Partner

Glooko

IceCure Medical

Diabeloop

Country

United States

Israel

France

Subscribe to see more

Subscribe to see more

News Snippet

Terumo and Glooko Announce Diabetes Technology Partnership to Deliver Integrated Diabetes Data Solution Globally.

The partnership will enable the integration of data from Terumo Corporation 's diabetes care devices such as MEDISAFE insulin patch pump and MEDISAFE Fit SmileTM blood glucose meters into Glooko 's diasend ® diabetes data management platform .

IceCure Inks Expanded Distribution Agreement with Terumo Corporation for Thailand – IceCure Expanded Agreement Builds from the Success of its Current Joint Activities in Japan and Singapore, to Bring its Cryoablation Products to Benefit More Patients in Asia .

CAESAREA , Israel , January 5 , 2021 -- IceCure Medical Ltd. , developer of the next generation cryoablation technology that destroys tumors by freezing without the need for surgery , today announced that an expanded distribution agreement in Thailand with its strategic partner , Terumo Corporation , a leading Japanese medical devices company with a global footprint , was signed on December 28 , 2020 .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

Terumo Service Providers

1 Service Provider

Terumo has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acquired

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.